USE OF ANTI-IL-12 ANTIBODIES IN TRANSPLANTATION REJECTION

摘要

Methods are disclosed for reducing or ameliorating chronic rejection of a transplanted tissue by administration of an anti-IL-12 antibody, alone or in combination with other beneficial therapeutic agents.